Global Weight Management Market – Unraveling the opportunities

“Global Weight Management Market Report” aims to identify and analyze products and services that specifically induce weight loss and enable individuals to maintain weight. The global weight management market is estimated to reach US$586 billion in 2014 from about US$363 billion in 2009.

Device and accessories is the largest market under weight management, and is expected to be US$181 billion in size by 2014, owing to the role of brands targeting the youth, and growing adoption rate in the female population. However, the highest CAGR of 14.7% from 2009 to 2014 is expected to come from the services segment. Artificial sweeteners used in low calorie food and beverages such as hoodia gordonii, inulin etc are driving the CAGR of ingredients in low calorie F&B to about 11.2% from 2009 to 2014. Emergence of new artificial sweeteners that claim to preserve the traditional flavors are gaining in demand.

Weight management service market is lucrative as it exhibits the highest CAGR over the period of 2009 to 2014. There are not many food chains which specialize in serving health food. Diet chains service providers are now expanding this low tapped segment by providing better and healthy food.

The market is currently restrained due to a confused positioning. Number of weight loss methods available in the market are making it difficult for market players to drive brand recall among the consumers. Failed attempts to reduce weight by the consumers discourage them to go in for further weight loss trials. Hence it is very essential for market players to understand the target audience and their specific needs to provide them umbrella solutions.

The significantly high rate of new products in the weight management segment necessitates industry participants to adopt proactive strategies. Moreover, the larger chunk of the market is not only driven by significant products such as fitness devices and food market, there also exist added opportunities in the minor market such as for fitness accessories. This necessitates a further need to understand clearly the characteristics and demand for the micro-markets so as to obtain a holistic view of the industry. North America is the largest market for weight management. However, Europe is catching up with an expected CAGR of 10.2% during the period 2009 to 2014, owing to increased adoption of the services and products. Asian markets are expected to ensure long term growth due to increased health awareness.

The weight management market is highly fragmented and dominated by the unorganized sector. The key players in the weight management market are Abbott Nutrition, GSK, Roche, Atkins Nutritionals, Brunswick, Jenny Craig, Kellogg, Merck, McNeil Nutritionals, Nestle, Reebok and Unilever. Agreements and collaborations, and new product launches are very popular strategies to combat competition. Both these strategies are consequential as several of the market players are entering into agreements and collaborations in order to promote their new products and to extend their presence in new geographies with no or very less cost compared to acquisitions. Our patent analysis indicates that rise in the obesity concerns has resulted in an apparent increase in the number of patents especially for weight loss ingredients and diet food products in 2008.

What makes our reports unique?

1. We provide the longest market segmentation chain in this industry- not many reports provide market breakdown upto level 5.

2. Each report is about 250 pages with 100+ market data tables, 40 competitive company profiles, analysis of 300 patents and minimum 50 micro markets, which are collectively exhaustive and mutually exclusive.

3. No single report by any other publisher provides market data for all the segments viz products, services, applications, ingredients, technology, and stakeholders in a single report for all the four geographies – US, Europe, APAC, ROW.

4. We provide 10% customization- normally it is seen that clients do not find specific market intelligence that they are looking for. Our customization Our customization will ensure that you necessarily get the market intelligence you are looking for and we get a loyal customer.

5. 15 pages of high level analysis including benchmarking strategies, best practices and the market?s cash cows (BCG matrix). We conduct detailed market positioning, product positioning and competitive positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders.

6. Comprehensive market analysis for pharmaceutical and biotech companies, medical device manufacturers, pharma-research labs, doctors, physicians and hospitals, medical/pharma associations, retailers and super-retailers, technology providers, and research and development (R&D) companies.

Key questions answered

1. Which are the high-growth segments/cash cows and how is the market segmented in terms of applications, products, services, ingredients, technologies, stakeholders?

2. What are market estimates and forecasts; which markets are doing well and which are not?

3. Where are the gaps and opportunities; what is driving the market?

4. Which are the key playing fields? Which are the winning edge imperatives?

5. How is the competitive outlook; who are the main players in each of the segments; what are the key selling products; what are their strategic directives, operational strengths and product pipelines? Who is doing what?

Powerful Research and analysis

The analysts working come from renowned publishers and market research firms globally adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies across the world. We are inspired to help our clients grow by providing qualitative business insights with our huge market intelligence repository.

For more information, please visit :
http://www.aarkstore.com/reports/Global-Weight-Loss-and-Diet-Management-2009-2014–16958.html
Or email us at [email protected] or call +919272852585

Drug Device Combination – a High Growth Market

Drug-device combination is defined as the combination of drugs and medical devices that can be chemically or physically united or co-packaged as separate, cross labeled products. The commercialization cycle from R&D to product shows the immense potential of the bundled offering. Currently, the market has a potential of US$10.6 billion and has been experiencing a growth of 15% CAGR for the past two years. In the next five years, the market is expected to grow at a CAGR of 11.8%. A future view of the drug-device combination is that these products will make single component medical devices obsolete.

The drug-eluting stents (DES) market is the largest segment in the drug-device combination market. This is supported by the fact that cardiovascular applications constitute about 64% of the entire drug-device combination applications market. However, it is the relatively smaller market of antimicrobial catheter that offers the highest growth potential over the next five years in the overall market.

The DES market is further segmented into stent grafts, coronary stents and peripheral vascular stents. Though coronary stents has the highest market share, peripheral vascular stents is expected to have the highest growth rate till 2014. The fastest growing macro-market of antimicrobial catheter is segmented into micro-markets such as urological catheter, cardiovascular catheter, peripherally inserted central catheter, oximetry catheter, thermodilution catheter and wound drainage catheter. Closed loop glucose monitor and insulin pump is also expected to record a high growth rate for the period 2009 to 2014. The two major segments: steroid eluting electrodes and photodynamic therapy are estimated to see the slowest growth rate due to a slow development of new products in these markets.

The challenges crippling the growth of the market in the future are expected to be the issues involved in cross industry partnerships, jurisdiction issues, patient safety and interoperability issues.

The drug-device combination market is not fragmented and the key players in this market are Medtronic, Boston Scientific Corp., Edwards Life sciences Corp., Stryker Corp., QLT Inc. etc. The maximum number of new product developments is expected to take place in the bone graft substitutes, advanced wound care products and antimicrobial catheter markets. Our patent analysis indicates that E.U. has filed for the maximum number of patents followed by the U.S.

There is an immense scope of collaboration between the drugs and medical devices companies in the areas of closed loop glucose monitor and insulin pump, bone graft substitutes and advanced wound care products market. However, the antibiotic bone cements and advanced wound care market is expected to face stiff competition in the next five years to come.

The incremental benefits of these combination products over the regular medical devices are increased efficiency, reduction in overall cost of treatment along with the rising awareness. The market holds significant opportunity for the early movers albeit with extensive research to develop new and improved products at competitive prices. Successful strategic alliances between companies from the drugs and medical devices areas assist them in taking advantage of the existing technologies by avoiding capital expenditure in R&D and take the drug-device combination market to new heights.

What makes our reports unique?

1. We provide the longest market segmentation chain in this industry- not many reports provide market breakdown upto level 5.

2. Each report is about 250 pages with 100+ market data tables, 40 competitive company profiles, analysis of 300 patents and minimum 50 micro markets, which are collectively exhaustive and mutually exclusive.

3. No single report by any other publisher provides market data for all the segments viz products, services, applications, ingredients, technology, and stakeholders in a single report for all the four geographies – US, Europe, APAC, ROW.

4. We provide 10% customization- normally it is seen that clients do not find specific market intelligence that they are looking for. Our customization Our customization will ensure that you necessarily get the market intelligence you are looking for and we get a loyal customer.

5. 15 pages of high level analysis including benchmarking strategies, best practices and the market?s cash cows (BCG matrix). We conduct detailed market positioning, product positioning and competitive positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders.

6. Comprehensive market analysis for pharmaceutical and biotech companies, medical device manufacturers, pharma-research labs, doctors, physicians and hospitals, medical/pharma associations, retailers and super-retailers, technology providers, and research and development (R&D) companies.

Key questions answered

1. Which are the high-growth segments/cash cows and how is the market segmented in terms of applications, products, services, ingredients, technologies, stakeholders?

2. What are market estimates and forecasts; which markets are doing well and which are not?

3. Where are the gaps and opportunities; what is driving the market?

4. Which are the key playing fields? Which are the winning edge imperatives?

5. How is the competitive outlook; who are the main players in each of the segments; what are the key selling products; what are their strategic directives, operational strengths and product pipelines? Who is doing what?

Powerful Research and analysis

The analysts working with MarketsandMarkets come from renowned publishers and market research firms globally adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies across the world. We, at MarketsandMarkets, are inspired to help our clients grow by providing qualitative business insights with our huge market intelligence repository.

For more information, please visit :
http://www.aarkstore.com/reports/Drug-and-Device-Combination-2009-2014–16959.html
Or email us at [email protected] or call +919272852585

Next-Generation Display Market More Greener

Environmental concerns are driving the need for greener and efficient display systems with better image quality and lower power consumption. The advances in nanotechnology and optoelectronics resulted in the introduction of next-generation display products. The next-generation display market comprises of those displays that consume lesser power than CRT, LCD, and plasma technologies. This market is segmented into flexible, transparent, three-dimensional, midair, double-sided, touchscreen, and 2D one-sided displays. The basic technologies in all these displays are LED, OLED, FED, electroluminescent and field emissive display, electrochromic, electrophoretic and electrowetting displays.

In 2008, the market size of next-generation display components was $6 billion that is expected to grow exponentially by 2014 because of the increasing use of the next generation display components in consumer electronics. This revenue potential highlights the immense opportunity in the next-generation display market.

Fragmentation and intense competition in the electronics industry has induced electronics manufacturers to improve upon the quality and reduce the prices of their products. Therefore, the expensive ingredients and large R&D investments required for next-generation displays act as a major restraint for the growth of this market. However, the evolution of the next-generation display market into a mainstream market is expected to overcome all these restraints.

Low labor cost and early initiatives have made Asia a dominant player in the next-generation display market, with a $3.7 billion or a 52% global market share in 2009. Asia’s large LED and OLED supplier-base also helps make the manufacture of these displays more cost-effective. Europe is expected to have the second-highest market for next-generation displays. The large consumer base of next-generation display devices in the U.S. and Europe makes them the most attractive markets for display components and device manufacturers.

Global Next-Generation Display Market by Products, 2009

In 2009, the market for 2D one-sided display is expected to dominate with a 72% market share, followed by the touchscreen display market with a share of 19%. The high market share of 2D one-sided display is mainly due to its low power consumption and its wide range of applications in industrial, advertising, entertainment, and consumer electronics sectors. The flexible display market is expected to grow at a high rate due to an increase in the demand for flexible, lightweight displays. 3D and midair display markets will have relatively smaller market shares but high growth rates due to the technical benefits they offer, such as uniform and stable 3D images.

Asia has the highest number of patents with a 39% share, closely followed by the U.S. with 35%. The increase in demand for lighter, thinner, efficient and low power consuming displays resulted in an increase in the number of patents filed in 2008 for LED, OLED and electrochromic displays.

The key players in this next-generation market include E-ink, RitDisplay, Samsung SDI, Sony, Toshiba, and Universal Display Corp.

Our analysis indicates that companies delivering improved and better performing next-generation display components will have an edge over their competitors. Agreements and collaborations as well as new product launches are some of the most popular strategies adopted by market players to stay ahead of competition and to expand into new geographies.

What makes our reports unique?

1. We provide the longest market segmentation chain in this industry- not many reports provide market breakdown upto level 5.

2. Each report is about 250 pages with 100+ market data tables, 40 competitive company profiles, analysis of 300 patents and minimum 50 micro markets, which are collectively exhaustive and mutually exclusive.

3. No single report by any other publisher provides market data for all the segments viz products, services, applications, ingredients, technology, and stakeholders in a single report for all the four geographies – US, Europe, APAC, ROW.

4. We provide 10% customization- normally it is seen that clients do not find specific market intelligence that they are looking for. Our customization Our customization will ensure that you necessarily get the market intelligence you are looking for and we get a loyal customer.

5. 15 pages of high level analysis including benchmarking strategies, best practices and the market?s cash cows (BCG matrix). We conduct detailed market positioning, product positioning and competitive positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders.

6. Comprehensive market analysis for pharmaceutical and biotech companies, medical device manufacturers, pharma-research labs, doctors, physicians and hospitals, medical/pharma associations, retailers and super-retailers, technology providers, and research and development (R&D) companies.

Key questions answered

1. Which are the high-growth segments/cash cows and how is the market segmented in terms of applications, products, services, ingredients, technologies, stakeholders?

2. What are market estimates and forecasts; which markets are doing well and which are not?

3. Where are the gaps and opportunities; what is driving the market?

4. Which are the key playing fields? Which are the winning edge imperatives?

5. How is the competitive outlook; who are the main players in each of the segments; what are the key selling products; what are their strategic directives, operational strengths and product pipelines? Who is doing what?

Powerful Research and analysis

The analysts working come from renowned publishers and market research firms globally adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies across the world. We are inspired to help our clients grow by providing qualitative business insights with our huge market intelligence repository.

For more information, please visit :
http://www.aarkstore.com/reports/Low-power-Next-Generation-Display-Market-2009-2014–16947.html
Or email us at [email protected] or call +919272852585

Nanophotonics is born out of the combination of three major sciences: photonics, nanotechnology, and optoelectronics. While photonics and optoelectronics have revolutionized the electronics and semiconductors market, nanotechnology has the greatest potential for further improvement, and hence has emerged as the most sought-after technology by big companies and research laboratories. In spite of it being in the nascent stage, nanophotonics is expected to make it to the mainstream market owing to its higher power efficiency, thermal resistivity, and operational life.

The nanophotonic component market is growing at a robust rate for the last few years and is expected to maintain a very high CAGR for the next few years. The market is expected to reach US$3.6 billion in 2014 at a CAGR of 100.7% from 2009 to 2014 and a similar growth pattern can be expected for the nanophotonics devices market as well. This market is expected to grow from a current market size of US$1.8 billion to US$58 billion in 2014.

Though most of the nanophotonic products are still under research, the available products such as nanophotonic LEDs, nanophotonic PV cells, nanophotonic OLEDs have been very successful in the market. Nanophotonic LEDs has the largest market share of US$106 million in 2009. However, considering the pace of progress in various other segments like near-field-optics, optical amplifiers, optical switches and holographic memory, it can be safely ascertained that holographic memory and optical switches are expected to have the highest growth rate in the next five years. Nanophotonic LEDs will still continue to be largest segment albeit with a slow growth rate.

In the nanophotonic LED market, the high beam LED has the highest market share followed by UV LED. In the fastest growing market of optical amplifiers, it is the optical fiber amplifier that commands the highest CAGR in the period 2009 to 2014 followed by semiconductor amplifiers. HDSS is also expected to grow with a CAGR comparable to that of optical amplifiers. OLED is estimated to be the slowest growing market. Lowering production costs and improving operational efficiencies would ensure opening of new opportunities for the nanophotonics market.

The market is very concentrated with only the market leaders like Osram, IBM, Samsung SDI, JDSU, etc doing extensive research in nanophotonics but as most of the application areas are related to electronics, this market is expected to attract a large number of players that would in turn increase the degree of competition.

Growth of Nanophotonic Products from 2009 – 2014

The graph indicates the forecasted growth rate of nanophotonics products from the year 2009 to 2014. The optical amplifiers are expected to grow at the maximum growth rate followed by the HDSS devices. The growth in the nanophotonics market is primarily due to the increasing demand from the Asian countries.

The key players in the nanophotonics component market are working at developing new products by forging strategic alliances with renowned universities, research laboratories and nanomaterial companies. These developments are focused on improving the operational parameters for the nanophotonic devices and grab the early mover’s advantages in the market.

Our patent analysis indicates that the U.S. has filed the highest number of patent applications in nanophotonics since 2006 followed by Europe. In the products category, nanophotonic LED accounts for the highest number of patents followed by nanostructures while OLED accounts for the lowest number.

What makes our reports unique?

We provide the longest market segmentation chain in this industry- not many reports provide market breakdown upto level 5.
Each report is about 250 pages with 100+ market data tables, 40 competitive company profiles, analysis of 300 patents and minimum 50 micro markets, which are collectively exhaustive and mutually exclusive.
No single report by any other publisher provides market data for all the segments viz products, services, applications, ingredients, technology, and stakeholders in a single report for all the four geographies – US, Europe, APAC, ROW.
We provide 10% customization- normally it is seen that clients do not find specific market intelligence that they are looking for. Our customization Our customization will ensure that you necessarily get the market intelligence you are looking for and we get a loyal customer.
15 pages of high level analysis including benchmarking strategies, best practices and the market?s cash cows (BCG matrix). We conduct detailed market positioning, product positioning and competitive positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders.
Comprehensive market analysis for pharmaceutical and biotech companies, medical device manufacturers, pharma-research labs, doctors, physicians and hospitals, medical/pharma associations, retailers and super-retailers, technology providers, and research and development (R&D) companies.

Key questions answered

Which are the high-growth segments/cash cows and how is the market segmented in terms of applications, products, services, ingredients, technologies, stakeholders?
What are market estimates and forecasts; which markets are doing well and which are not?
Where are the gaps and opportunities; what is driving the market?
Which are the key playing fields? Which are the winning edge imperatives?
How is the competitive outlook; who are the main players in each of the segments; what are the key selling products; what are their strategic directives, operational strengths and product pipelines? Who is doing what?

Powerful Research and analysis

The analysts working come from renowned publishers and market research firms globally adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies across the world. We, are inspired to help our clients grow by providing qualitative business insights with our huge market intelligence repository.

For more information, please visit :
http://www.aarkstore.com/reports/Nanophotonics-Advanced-Technologies-and-Global-Market-2009-2014–16938.html
Or email us at [email protected] or call +919272852585

Report description (http://www.aarkstore.com/reports/Global-Baby-Food-Market-2009%E2%80%932014–23081.html)

Baby food is a nutritional supplement of breast milk for babies aged from zero to three years. Their availability in both states-solid and liquid and with various tastes and flavors adds to their easy acceptance by both parents and babies alike. Time constraint in modern parents, both in developed as well as developing countries, have dwindled the home-made baby food and has swung the baby food diet in favor of commercially available baby food. The U.S. and Europe hold a major share of the global baby food market. However, emerging economies such as China, India, Brazil, Russia, and Romania also represent a high growth rate.

As people across the globe are getting aware of the important role of baby foods in meeting the nutrient requirements of a baby, there is a huge boost in the market. Major challenges for the baby food industry are low birth rates and static market conditions in developed countries and allergy & intolerance of milk and milk products in babies. However, opportunities for the baby food industry is immense for baby food companies as there is large untapped market in developing economies and new product development with evolving food technology is expected to attract more customers in future.

The global baby food market is expected to be worth US$37.6 billion by 2014, out of which the North American market will account for nearly 37% of the total revenues. The global market is expected to record a CAGR of 5.0% from 2009 to 2014. The bottled baby food market is the largest segment; and is expected to reach US$9.9 billion by 2014 at a CAGR of 4.9%. Baby cereals and frozen baby foods markets are estimated to record revenues of US$9.9 billion and US$ 7.8 billion respectively in 2014 on account of the increasing awareness about baby food products especially in Asian region. Baby soup and baby snacks markets are estimated to be US$ 3.9 billion and US$5.9 billion in 2014. However, these two market present good opportunities as limited but growing numbers of products are available in the market.

The North American market is the largest geographical segment; and is expected to be worth US$14.17 billion by 2014. The second largest segment is Europe, with a CAGR of 4.4%. It is expected to reach US$10.8 billion by 2014. However, market size of Asia is expected to increase at the highest CAGR of 8.6% from the year 2009 to 2014.

Scope of the Report

This report aims to identify and analyze products, health benefits, ingredients and age group analysis for baby food market. The report provides in-depth market estimates and forecast for global baby food market as follows:

• Baby food – products
Baby cereals, bottled baby foods, frozen baby foods, baby snacks and baby soups.

• Baby food – age group
Newborn (zero months to six months), Infant (six months to one year), Toddler (one year to two years), Pre-schooler (Two year to three years)

• Baby food – health benefits

Immune system, brain and eye development, muscular growth, bones and teeth development, blood enhancement, nervous system, vascular system and others
Each section will provide market data, market drivers, trends and opportunities, top-selling products, key players, and competitive outlook. This report will also provide more than 100 market tables for various geographic regions covering the sub-segments and micro-markets. In addition, the report also provides 32 company profiles for each of its sub-segments.
What makes our reports unique/ why you should buy this report?

- We provide the longest market segmentation chain in this industry- not many reports provide market breakdown up to level 3.
- Each report is about 210 pages with 100+ market data tables, 32 competitive company profiles, minimum 40 micro markets analyzed which are collectively exhaustive and mutually exclusive, 100 patents analyzed,
- No single report by any other publisher provides market data for all the segments viz products, ingredients, health benefits and age-group in a single report for all the four geographies together- US, Europe, APAC, ROW.
- We provide 10% customization- normally it is researched that clients do not specific market intelligence what they are looking for. Our customization will ensure that you necessarily get the market intelligence you are looking for and we get a loyal customer.
- 15 pages of high level analysis including benchmarking strategies. We conduct detailed market positioning, product positioning and competitive positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders.
- Comprehensive market analysis for Pharmaceutical and biotech companies, Pharma-research labs, Doctors, physicians and hospitals, Medical/Pharma associations, Retailers and super-retailers, Technology providers and Research and development (R&D) companies.

Key questions answered

- Which is the high growth segments/cash cows; how is the market segmented in terms of products, ingredients, health benefits and age-group.
- What are market estimates and forecast; which are markets are doing well and which are not?
- Where are the gaps and opportunities; what is driving the market;
- Which are the key playing fields? Which are the winning edge imperatives?
- How is the competitive outlook; who are the main players in each of the segments; what are the key selling products; what are their strategic directives, operational strength and product pipelines? Who is doing what?

Powerful Research and analysis
The analyst working with come from the renowned publishers and market research firms globally adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a database of hundred thousand of key industry participants and draw on our relationship with more than 900 market research companies globally. We, are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository

Executive Summary

Baby Food

Baby food is a nutritional supplement of breast milk for babies aged from zero to three years. Their availability in both states-solid and liquid and with various tastes and flavors adds to their easy acceptance by both parents and babies alike. Time constraint in modern parents, both in developed as well as developing countries, have dwindled the home-made baby food and has swung the baby food diet in favor of commercially available baby food. The U.S. and Europe hold a major share of the global baby food market. However, emerging economies such as China, India, Brazil, Russia, and Romania also represent a high growth rate.

As people across the globe are getting aware of the important role of baby foods in meeting the nutrient requirements of a baby, there is a huge boost in the market. Major challenges for the baby food industry are low birth rates and static market conditions in developed countries and allergy & intolerance of milk and milk products in babies. However, opportunities for the baby food industry is immense for baby food companies as there is large untapped market in developing economies and new product development with evolving food technology is expected to attract more customers in future.

The key players in the baby food market are Nestlé SA, H.J. Heinz, Bristol-Myers Squibb, DANONE and Hero. Nestlé SA is the market leader in the global baby food products market. Baby food market, though an old concept, is growing at a robust rate for the last few years and is expected to maintain a healthy CAGR for the next few years. The baby food market is expected to reach $37.6 billion in 2014 at a CAGR of 5.0% from 2009. The segment with the highest growth potential is expected to be frozen baby food followed by bottled baby food products and baby cereals.

The major segments in the baby food product market are baby cereals, bottled baby foods, frozen baby foods, baby snacks and baby soups. Furthermore, important micro-markets of baby food products include juice, puree, milk products, puff, biscuits and frozen fruits. With the advancement in the baby food market, specially prepared foods for different age groups like new born, infants, toddlers and preschoolers are available in the market.

The baby food companies are focusing mainly on developing fortified baby food that is easily digestible at competitive price. With the evolving food technologies they are introducing varieties of baby food products such as baby soup and frozen baby foods. The technology enables them to offer quality product to their customers with enhanced benefits like optimum nutrients content for babies.

Indicates the estimated market size of baby food products in 2009. The bottled baby foods is expected to enjoy the maximum market share followed by the baby cereals in 2009. The growth in the baby food market is primarily due to the increasing demand from the Asian countries.

The patent analysis of baby food products indicate that maximum number of patents has been registered for bottled baby food that accounts for 70% of the total numbers of patents. Baby cereals is second with 16% of the total patents registered followed by baby snacks with 12% of the total patents registered. Also geography wise, the U.S. accounts for 58% of the total patents registered in baby food products followed by Europe with 30%.

For more information, please visit :
http://www.aarkstore.com/reports/Global-Baby-Food-Market-2009%E2%80%932014–23081.html
Or email us at [email protected] or call +919272852585